Chronic atrophic gastritis
Conditions
Interventions
Observation group:Shutiao Weini Formula
Control group:Placebo
Sponsors
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 to 70 years, of any gender; 2. Those whose gastroscopy and pathology meet both the Western diagnostic criteria for chronic atrophic gastritis; 3. Those who meet the criteria of liver and stomach stagnation and heat, and phlegm and stagnation of each other; 4. Those who are negative for H. pylori infection; 5. Those who are autonomous and have signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Within three months or who are participating in a clinical trial of another drug; 2. Combined acute gastritis, peptic ulcers, acute hepatobiliary disorders and other serious digestive disorders; 3. Upper abdominal symptoms cannot be ruled out as being due to cardiovascular disease; 4. Combination of serious primary cardiovascular, haematological or respiratory diseases or other conditions that seriously affect the quality of survival; 5. Patients with CAG Type A; 6. Pregnant and breastfeeding women; 7. Mentally and speech impaired and mentally ill persons; 8. Persons with a history of allergy to the drug components tested in this study; 9. Those deemed by the investigator to be unsuitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical effect; | — |
Secondary
| Measure | Time frame |
|---|---|
| Gastric mucosal pathology;Gastroscopic efficacy;Chinese Medicine Symptom Score;Stomach function;Ferroptosis Related Indicators;Safety; | — |
Countries
China
Contacts
Public ContactXing Lianjun
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed